Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 1Neoplasm Micrometastasis 1Melanoma 1Lymphatic Metastasis 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Fluorescence × Clear all
NCT02142244 2017-02-02

Fluorescence Surgery for Sentinel Node Identification in Melanoma

Barretos Cancer Hospital

Phase NA Unknown
318 enrolled
Dermatologic

Lymphatic Metastasis, Melanoma, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡